Saro Khemichian, MD

Dr. Saro Khemichian is a board certified transplant hepatologist who received his medical degree from University of Southern California Keck School of medicine. He then went on to complete his residency in Internal Medicine followed by Gastroenterology fellowship at LAC+USC Medical Center in Los Angeles. Dr. Khemichian then completed an extra year of training for Transplant Hepatology at Keck Medical Center of USC.

Dr. Khemichian’s clinical interests include gastroenterology, hepatitis B, hepatitis C, chronic liver disease and liver transplantation. His research interests include complications of chronic liver disease, liver transplant, and treatment of hepatitis C infection.

• Department of Medicine, USC: Intern of the Year Award, 2004
• Georgetown University: Physiology Student of the Year, 1999

• Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US J Hepatol. 2023 12; 79(6):1408-1417. . View in PubMed
• The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure J Hepatol. 2023 09; 79(3):717-727. . View in PubMed
• Autoimmune hepatitis triggered by COVID-19 Intern Med J. 2021 Jul; 51(7):1182-1183. . View in PubMed
• Hepatorenal Syndrome Crit Care Clin. 2021 Apr; 37(2):321-334. . View in PubMed
• Use of Hepatitis B Virus-Positive Organs in Organ Transplantation Clin Liver Dis. 2021 11; 25(4):841-857. . View in PubMed
• Advances in management of hepatorenal syndrome Curr Opin Nephrol Hypertens. 2021 09 01; 30(5):501-506. . View in PubMed
• Deficits in Advance Care Planning for Patients With Decompensated Cirrhosis at Liver Transplant Centers JAMA Intern Med. 2021 05 01; 181(5):652-660. . View in PubMed
• Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures Eur J Gastroenterol Hepatol. 2021 04 01; 33(4):541-546. . View in PubMed
• Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Semin Thromb Hemost. 2020 Sep; 46(6):682-692. . View in PubMed
• Treatment and Outcomes of Early Stage Breast Cancer in Patients with Hepatic Dysfunction J Surg Res. 2020 12; 256:212-219. . View in PubMed
• Acute Kidney Injury After Liver Transplantation Transplantation. 2018 10; 102(10):1636-1649. . View in PubMed
• Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort Hepatol Commun. 2018 04; 2(4):354-363. . View in PubMed
• Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern California J Clin Gastroenterol. 2016 08; 50(7):602-7. . View in PubMed
• Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding Hepatology. 2016 08; 64(2):549-55. . View in PubMed
• Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation Dig Dis Sci. 2015 Sep; 60(9):2807-12. . View in PubMed
• Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation Transplant Direct. 2015 Jul; 1(6):e21. . View in PubMed
• Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure Transplantation. 2012 Aug 27; 94(4):411-6. . View in PubMed
• Hepatic dysfunction in hyperthyroidism Gastroenterol Hepatol (N Y). 2011 May; 7(5):337-9. . View in PubMed
• Pulmonary vein leiomyosarcoma Intern Med J. 2006 Dec; 36(12):793-4. . View in PubMed

• Terrault, Norah
• Nadim, Mitra
• Zhou, Kali
• Ou, Jing-Hsiung